2Pitt B, Remrue W, Zannad F, et al. Eplerenone, a selective aldostetone blocker in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003,348(4) :1309.
3Rocha R, Rudolph AE, Ffierdich GE, et al. Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol. 2002,283 : H1802.
4Satoh M, lwasaka J, Nakamura M, et al. Increased expression of tumor necrosis factor -α converting enzyme .rod tumor necrosis factor -α in peripheral blood mononuclear cells in patiems with advanced congestive heart failure. Eur J Heart Fail. 2004,6:869.
5Satoh M, Ishikawa Y, Minami Y, et al. Eplerenone inhibits turnout necrosis factor a shedding process by tumour necrosis factor a converting enzyme in monocytes from patients with congestive heart failure. Scientific Letter. 2006,92:979.
6Sun Y, Zhang J, Lu L, et al. Aldosterone - induced inflammation in the rat heart: role of oxidative stress. Am J Pathol. 2002 161:1773.
7Kuster GM, Kotlyar E, Rude MK. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload. Circulation. 2005, 111:420.
8Hansen PR, Rieneck K, Bendtzen K. Spironolactone inhibits production of proinflammatory cytokines by human mononuclear cells. Immunol Lett. 2004, 91:87.
9Satoh M, Iwasaka J, Nakamura M, et al. Increased expression of tumor necrosis factor-a converting enzyme and tumor necrosis factor-a in periph- eral blood mononuclear cells in patients with advanced congestive heart failure[ J]. Eur J Heart Fail ,2004 ;6:869-75.
10Satoh M, Ishikawa Y, Minami Y, et al. Eplerenone inhibits tumour necrosis factor a shedding process by tumour necrosis factor a converting enzyme in monocytes from patients with congestive heart failure [J]. Sci Lett ,2006 ;92:979-80.
